Q3 2024 Cigna Group Earnings Call Transcript
Key Points
- The Cigna Group (CI) reported strong third-quarter financial results with total revenue of $63.7 billion and adjusted earnings per share of $7.51.
- Evernorth Health Services, a growth platform of The Cigna Group (CI), delivered strong top and bottom line contributions, driven by market-leading innovation and affordability initiatives.
- The company is on track to deliver full-year adjusted earnings per share of at least $28.40 in 2024, representing more than 13% year-over-year growth.
- The Cigna Group (CI) has successfully expanded its biosimilar offerings, with significant adoption of HUMIRA biosimilars, contributing to cost savings for patients and clients.
- The company has repurchased approximately $5.7 billion of its common stock year-to-date, demonstrating confidence in its business strength and sustainable growth.
- The Cigna Group (CI) recorded a noncash, after-tax net realized investment loss of $1 billion related to VillageMD, impacting shareholders' net income.
- The company faces headwinds from lower net investment income due to the absence of the VillageMD dividend.
- There is a potential for constrained overhead from the sale of the Medicare Advantage business, which the company will need to mitigate over time.
- The Medicare Advantage market is currently challenged due to elevated medical costs and significant changes in star ratings, contributing to operational disruptions.
- The company anticipates continued strategic investments across its portfolio, which may impact short-term financial performance.
Ladies and gentlemen, thank you for standing by for the Cigna Group's Third Quarter 2024 Results Review. (Operator Instructions) As a reminder, ladies and gentlemen, this conference, including the Q&A session is being recorded.
We will begin by turning the conference over to Ralph Giacobbe. Please go ahead.
Thanks, operator. Good morning, everyone. Thank you for joining today's call. I'm Ralph Giacobbe, Senior Vice President of Investor Relations. With me on the line this morning are David Cordani, the Cigna Group's Chairman and Chief Executive Officer; Brian Evanko, Chief Financial Officer of the Cigna Group and President and Chief Executive Officer of Cigna Healthcare; and Eric Palmer, President and Chief Executive Officer of Evernorth Health Services.
In our remarks today, David and Brian will cover a number of topics, including our third quarter financial results and our financial outlook for 2024. Following their prepared remarks, David, Brian, and Eric will be available for Q&
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
